{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:42:14Z","timestamp":1789789334091,"version":"4.0.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.beem.2015.01.003","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T10:46:36Z","timestamp":1423305996000},"page":"353-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Novel approaches to short stature therapy"],"prefix":"10.1016","volume":"29","author":[{"given":"Jan M.","family":"Wit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Oostdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2015.01.003_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ecl.2009.06.004","article-title":"Strategies for maximizing growth in puberty in children with short stature","volume":"38","author":"Mauras","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.beem.2015.01.003_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrendo.2013.71","article-title":"Treatment of children and adolescents with idiopathic short stature","volume":"9","author":"Ranke","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMcp1213178","article-title":"Clinical practice. Short stature in childhood\u2013challenges and choices","volume":"368","author":"Allen","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2015.01.003_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ncpendmet0450","article-title":"Male pubertal development and the role of androgen therapy","volume":"3","author":"Richmond","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000358195","article-title":"Safety and efficacy of oxandrolone in growth hormone-treated girls with turner syndrome: evidence from recent studies and recommendations for use","author":"Sas","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib6","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2015.01.003_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrendo.2011.161","article-title":"Aromatase inhibitors in pediatrics","volume":"8","author":"Wit","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MED.0b013e32832b20a8","article-title":"Androgen therapy for delayed male puberty","volume":"16","author":"Ambler","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"Suppl. 279","key":"10.1016\/j.beem.2015.01.003_bib9","first-page":"147","article-title":"Testosterone treatment of constitutional delay in growth and development: effect of dose on predicted versus definitive height","volume":"113","author":"Martin","year":"1986","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/JPEM.1996.9.5.511","article-title":"Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty","volume":"9","author":"Arrigo","year":"1996","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/adc.71.4.315","article-title":"Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate","volume":"71","author":"Albanese","year":"1994","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.beem.2015.01.003_bib12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/jcem-69-6-1109","article-title":"Oxandrolone in constitutionally delayed growth, a longitudinal study up to final height","volume":"69","author":"Joss","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/BF01958637","article-title":"The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty","volume":"154","author":"Schroor","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jc.2009-1821","article-title":"Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome","volume":"95","author":"Menke","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib15","doi-asserted-by":"crossref","first-page":"d1980","DOI":"10.1136\/bmj.d1980","article-title":"Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial","volume":"342","author":"Gault","year":"2011","journal-title":"Br Med J"},{"key":"10.1016\/j.beem.2015.01.003_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000317529","article-title":"Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome","volume":"75","author":"Zeger","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-12-0404","article-title":"Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome","volume":"168","author":"Freriks","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jpeds.2009.05.031","article-title":"Effects of treatment with oxandrolone for 4 years on the frequency of severe arithmetic learning disability in girls with Turner syndrome","volume":"155","author":"Ross","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/jc.2002-021000","article-title":"Androgen-responsive aspects of cognition in girls with Turner syndrome","volume":"88","author":"Ross","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000356924","article-title":"Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study","volume":"81","author":"Perry","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2006-1374","article-title":"Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group","volume":"92","author":"Bondy","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1005669","article-title":"Growth hormone plus childhood low-dose estrogen in Turner's syndrome","volume":"364","author":"Ross","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2015.01.003_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.54.1.164","article-title":"Use of estrogen in young girls with Turner syndrome: effects on memory","volume":"54","author":"Ross","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2015.01.003_bib24","doi-asserted-by":"crossref","first-page":"E1754","DOI":"10.1210\/jc.2013-4518","article-title":"Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial","volume":"99","author":"Quigley","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib25","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib26","doi-asserted-by":"crossref","first-page":"812517","DOI":"10.1186\/1687-9856-2009-812517","article-title":"Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty","volume":"2009","author":"Rahhal","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib27","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/jc.2004-1863","article-title":"Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty","volume":"90","author":"Tanaka","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib28","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1210\/jc.2007-0321","article-title":"Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity","volume":"92","author":"Lazar","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib29","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1210\/jc.2007-2183","article-title":"Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs","volume":"93","author":"Brito","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function","volume":"93","author":"Pasquino","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2009-0793","article-title":"The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study","volume":"95","author":"Magiakou","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1515\/jpem.2011.006","article-title":"Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand","volume":"24","author":"Jaruratanasirikul","year":"2011","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1687-9856-2011-7","article-title":"Efficacy of leuprolide acetate 1-month depot for central precocious puberty (CPP): growth outcomes during a prospective, longitudinal study","volume":"2011","author":"Lee","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/09513590.2010.507289","article-title":"Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment","volume":"27","author":"Poomthavorn","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpeds.2013.01.021","article-title":"Time to menarche and final height after histrelin implant treatment for central precocious puberty","volume":"163","author":"Gillis","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.6065\/apem.2014.19.1.27","article-title":"Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty","volume":"19","author":"Baek","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"Suppl. 3","key":"10.1016\/j.beem.2015.01.003_bib37","doi-asserted-by":"crossref","first-page":"U101","DOI":"10.1530\/eje.0.151u101","article-title":"Can we increase adolescent growth?","volume":"151","author":"Carel","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3476(52)80205-7","article-title":"Tables for predicting adult height from skeletal age","volume":"40","author":"Bayley","year":"1952","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000185432","article-title":"Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method","volume":"47","author":"Kauli","year":"1997","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2015.01.003_bib40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cen.12319","article-title":"Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades","volume":"80","author":"Lazar","year":"2014","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.beem.2015.01.003_bib41","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","article-title":"Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience","volume":"86","author":"Klein","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib42","first-page":"1","article-title":"Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results","volume":"58","author":"Mul","year":"2002","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2015.01.003_bib43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1745-7262.2008.00409.x","article-title":"Treatment of central precocious puberty by GnRH analogs: long-term outcome in men","volume":"10","author":"Bertelloni","year":"2008","journal-title":"Asian J Androl"},{"key":"10.1016\/j.beem.2015.01.003_bib44","first-page":"3318","article-title":"Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development","volume":"81","author":"Carel","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib45","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa013555","article-title":"Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature","volume":"348","author":"Yanovski","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2015.01.003_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2265.2005.02323.x","article-title":"Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone","volume":"63","author":"Mul","year":"2005","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.beem.2015.01.003_bib47","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1651-2227.2004.tb02629.x","article-title":"Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty","volume":"93","author":"Tuvemo","year":"2004","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib48","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/jcem.87.2.8202","article-title":"Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy","volume":"87","author":"van der Sluis","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mce.2006.04.012","article-title":"Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function","volume":"254\u2013255","author":"Heger","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-09-1102","article-title":"GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome","volume":"163","author":"Chiavaroli","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000182690","article-title":"Gonadotropin releasing hormone analogue and growth hormone therapy in precocious and premature puberty following cranial irradiation for acute lymphoblastic leukaemia","volume":"39","author":"Thomas","year":"1993","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2015.01.003_bib52","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0022-3476(05)80232-X","article-title":"Height prognosis of children with true precocious puberty and growth hormone deficiency \u2013 effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone","volume":"120","author":"Cara","year":"1992","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib53","first-page":"229","article-title":"Adult height in 24 patients treated for growth hormone deficiency and early puberty","volume":"82","author":"Adan","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib54","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1542\/peds.104.S5.1014","article-title":"Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience","volume":"104","author":"Kohn","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2015.01.003_bib55","first-page":"569","article-title":"Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial","volume":"85","author":"Mericq","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib56","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jcem.86.10.7910","article-title":"The effect of pubertal delay by GnRH agonist in GH-deficient children on final height","volume":"86","author":"Mul","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib57","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/jcem.86.5.7439","article-title":"The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study","volume":"86","author":"Saggese","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2007-1572","article-title":"Height gain with combined growth hormone and gonadotropin-releasing hormone analog therapy in two pubertal siblings with a growth hormone-releasing hormone receptor mutation","volume":"93","author":"Walenkamp","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/jcem.87.1.8148","article-title":"Effects of treatment with GH alone or in combination with LHRH analog on bone mineral density in pubertal GH-deficient patients","volume":"87","author":"Mericq","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib60","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/jc.2012-1987","article-title":"Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial","volume":"97","author":"Lem","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib61","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2009-1577","article-title":"Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency","volume":"95","author":"Scalco","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1210\/jcem.84.2.5431","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone","volume":"84","author":"Pasquino","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1515\/JPEM.2003.16.7.1005","article-title":"Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution","volume":"16","author":"Pucarelli","year":"2003","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000183889","article-title":"Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist","volume":"41","author":"Job","year":"1994","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2015.01.003_bib65","first-page":"3596","article-title":"Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone","volume":"80","author":"Balducci","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib66","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-3476(95)70473-6","article-title":"Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls","volume":"126","author":"Saggese","year":"1995","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1515\/JPEM.1997.10.6.623","article-title":"GH and GnRH analog treatment in children who enter puberty at short stature","volume":"10","author":"Tanaka","year":"1997","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2265.1998.00499.x","article-title":"Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty","volume":"49","author":"Lanes","year":"1998","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.beem.2015.01.003_bib69","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem.85.2.6387","article-title":"Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone","volume":"85","author":"Pasquino","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib70","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/jc.2006-2272","article-title":"Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty","volume":"92","author":"van Gool","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/jpem-2013-0210","article-title":"Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential","volume":"27","author":"Toumba","year":"2014","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib72","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1651-2227.2007.00235.x","article-title":"Long-term psychosocial consequences of hormone treatment for short stature","volume":"96","author":"Visser-van Balen","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib73","first-page":"1511","article-title":"Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia","volume":"86","author":"Quintos","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib74","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1210\/jc.2004-2128","article-title":"Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia","volume":"90","author":"Lin-Su","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib75","first-page":"983","article-title":"Effect of GnRH analogue on height potential in patients with severe growth hormone insensitivity syndrome treated with IGF-I","volume":"24","author":"El","year":"2011","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000351958","article-title":"Adult and near-adult height in patients with severe insulin-like growth factor-I deficiency after long-term therapy with recombinant human insulin-like growth factor-I","volume":"80","author":"Backeljauw","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib77","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1210\/jc.2005-1693","article-title":"Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone","volume":"91","author":"Vottero","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1297\/cpe.21.35","article-title":"Combined treatment with gonadotropin-releasing hormone analog and anabolic steroid hormone increased pubertal height gain and adult height in boys with early puberty for height","volume":"21","author":"Tanaka","year":"2012","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib79","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jcem.87.2.8242","article-title":"Estrogen mini-dose replacement during GnRH agonist therapy in central precocious puberty: a pilot study","volume":"87","author":"Lampit","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib80","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1210\/jc.2004-1566","article-title":"Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred","volume":"90","author":"Binder","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib81","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpeds.2006.04.027","article-title":"Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole","volume":"149","author":"Kreher","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib82","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1515\/JPEM.2008.21.10.995","article-title":"Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty","volume":"21","author":"Eyssette-Guerreau","year":"2008","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib83","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1515\/JPEM.2009.22.12.1163","article-title":"Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor","volume":"22","author":"Mitre","year":"2009","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib84","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.1542\/peds.2010-0596","article-title":"Bicalutamide and third-generation aromatase inhibitors in testotoxicosis","volume":"126","author":"Lenz","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2015.01.003_bib85","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1515\/jpem.2010.161","article-title":"Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT)","volume":"23","author":"Reiter","year":"2010","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib86","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/MOP.0b013e32833ab888","article-title":"Use of aromatase inhibitors in children and adolescents: what's new?","volume":"22","author":"Diaz-Thomas","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1297\/cpe.23.53","article-title":"Third-generation aromatase inhibitor improved adult height in a japanese boy with testotoxicosis","volume":"23","author":"Yoshizawa-Ogasawara","year":"2014","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.beem.2015.01.003_bib88","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0140-6736(00)04895-9","article-title":"A\u00a0specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial","volume":"357","author":"Wickman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2015.01.003_bib89","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1210\/jc.2005-1392","article-title":"Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial","volume":"90","author":"Hero","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib90","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2265.2006.02499.x","article-title":"Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty","volume":"64","author":"Hero","year":"2006","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.beem.2015.01.003_bib91","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jc.2007-1559","article-title":"Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years","volume":"93","author":"Mauras","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib92","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000315482","article-title":"A\u00a0double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature","volume":"74","author":"Salehpour","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib93","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1515\/JPEM.2005.18.3.285","article-title":"The effect of letrozole on bone age progression, predicted adult height, and adrenal gland function","volume":"18","author":"Karmazin","year":"2005","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib94","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1515\/jpem-2011-0435","article-title":"Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature","volume":"25","author":"Krebs","year":"2012","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib95","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1515\/jpem-2013-0470","article-title":"Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and\/or rapid pubertal progress: a retrospective chart review","volume":"27","author":"Shams","year":"2014","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib96","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jbmr.56","article-title":"Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty","volume":"25","author":"Hero","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2015.01.003_bib97","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000317434","article-title":"Off-label use of aromatase inhibitors to promote taller stature: is it safe","volume":"74","author":"Dunkel","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib98","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1210\/jc.2014-2432","article-title":"Letrozole vs anastrozole for height augmentation in short pubertal males: first year data","volume":"99","author":"Neely","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2015.01.003_bib99","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(03)00128-8","article-title":"Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial","volume":"143","author":"Eugster","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2015.01.003_bib100","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"Am J Hum Genet"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X15000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X15000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:49:17Z","timestamp":1761497357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X15000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1521690X15000159"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2015.01.003","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel approaches to short stature therapy","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2015.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}